CTOs on the Move

ALung Technologies

www.alung.com

 
ALung Technologies has developed the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis,a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patients lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).
  • Number of Employees: 5K-10K
  • Annual Revenue: $1-10 Million
  • www.alung.com
  • 2500 Jane St Ste 1
    Pittsburgh, PA USA 15203
  • Phone: 412.697.3370

Executives

Name Title Contact Details

Funding

ALung Technologies raised $10.53M on 12/04/2015
ALung Technologies raised $36M on 04/12/2017

Similar Companies

Kalamazoo X-Ray Sales

Kalamazoo X-Ray Sales is a Portage, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vicarious Surgical

At Vicarious Surgical we are revolutionizing the field of surgical robotics. We seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. We have reimagined what is possible by building a human-like surgical robot and combining it with the world`s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.

Sensivida

Holland Applied Technologies

Holland Applied Technologies is a Burr Ridge, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.